Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data sources
1.5.1 Primary
1.5.2 Secondary
1.5.2.1 Paid sources
1.5.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising demand for early detection and classification of cancer
3.2.1.2 Increasing prevalence of cancer
3.2.1.3 Growing adoption of precision medicine
3.2.1.4 Surging advancements in healthcare infrastructure
3.2.2 Industry pitfalls & challenges
3.2.2.1 High procurement and implementation cost
3.2.2.2 High impact of regulations
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter's analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Component, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Software solutions
5.3 Hardware
5.4 Services
Chapter 6 Market Estimates and Forecast, By Cancer Type, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Breast cancer
6.3 Lung cancer
6.4 Prostate cancer
6.5 Colorectal cancer
6.6 Brain tumor
6.7 Other cancer types
Chapter 7 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Diagnostics
7.3 Radiation therapy
7.4 Research and development
7.5 Chemotherapy
7.6 Immunotherapy
Chapter 8 Market Estimates and Forecast, By End-use, 2018 – 2032 ($ Mn)
8.1 key trends
8.2 Hospitals
8.3 Diagnostics centers
8.4 Specialty clinics
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Mexico
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Azra AI.
10.2 ConcertAI.
10.3 Digital Diagnostics Inc.
10.4 GE HealthCare Technologies Inc.
10.5 International Business Machines Corporation
10.6 Intel Corporation
10.7 Median Technologies SA
10.8 NVIDIA Corporation
10.9 PathAI, Inc.
10.10 Siemens Healthineers AG
